Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Warfarin and the inhibition of vitamin K activity by an oxide metabolite.

× No keyword cloud information.

20 in total

1. Mycobacterium tuberculosis vitamin K epoxide reductase homologue supports vitamin K-dependent carboxylation in mammalian cells.

Authors: Jian-Ke Tie; Da-Yun Jin; Darrel W Stafford
Journal: Antioxid Redox Signal Date: 2011-11-22 Impact factor: 8.401

Review 2. Pharmacogenetics of warfarin: challenges and opportunities.

Authors: Ming Ta Michael Lee; Teri E Klein
Journal: J Hum Genet Date: 2013-05-09 Impact factor: 3.172

3. The relationship between inhibition of vitamin K1 2,3-epoxide reductase and reduction of clotting factor activity with warfarin.

Authors: I A Choonara; R G Malia; B P Haynes; C R Hay; S Cholerton; A M Breckenridge; F E Preston; B K Park
Journal: Br J Clin Pharmacol Date: 1988-01 Impact factor: 4.335

4. Enantiomers of warfarin and vitamin K1 metabolism.

Authors: I A Choonara; B P Haynes; S Cholerton; A M Breckenridge; B K Park
Journal: Br J Clin Pharmacol Date: 1986-12 Impact factor: 4.335

5. Abnormal vitamin K metabolism in the presence of normal clotting factor activity in factory workers exposed to 4-hydroxycoumarins.

Authors: B K Park; I A Choonara; B P Haynes; A M Breckenridge; R G Malia; F E Preston
Journal: Br J Clin Pharmacol Date: 1986-03 Impact factor: 4.335

Review 6. Vitamin K and hepatocellular carcinoma: The basic and clinic.

Authors: Xia Jinghe; Toshihiko Mizuta; Iwata Ozaki
Journal: World J Clin Cases Date: 2015-09-16 Impact factor: 1.337

7. A study of the relationship between the pharmacokinetics and the pharmacodynamics of the 4-hydroxycoumarin anticoagulants warfarin, difenacoum and brodifacoum in the rabbit.

Authors: A M Breckenridge; S Cholerton; J A Hart; B K Park; A K Scott
Journal: Br J Pharmacol Date: 1985-01 Impact factor: 8.739

Warfarin and the inhibition of vitamin K activity by an oxide metabolite.